Outcomes of Pediatric Patients with Crohn’s Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission

Figure 3

Comparison of sustained remission effect in each treatment group. (a) Sustained remission rate at 0.5, 1, and 2 years after induction therapy between IFX+IFX and EEN+6-MP/MTX groups. (b) Kaplan–Meier curve showing sustained remission time from maintenance treatment to first recurrence. The log-rank test was used to compare differences among the groups.

(a)

(b)